{
    "root": "3f6e35d0-9eb1-4757-9526-c9ea922f0efe",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Iluvien",
    "value": "20250321",
    "ingredients": [
        {
            "name": "FLUOCINOLONE ACETONIDE",
            "code": "0CD5FD6S2M"
        },
        {
            "name": "POLYVINYL ALCOHOL",
            "code": "532B59J990"
        },
        {
            "name": "WATER",
            "code": "059QF0KO0R"
        }
    ],
    "indications": "ILUVIEN is a corticosteroid indicated for: the treatment of diabetic macular edema (DME) in patients who have been previously treated with a course of corticosteroids and did not have a clinically significant rise in intraocular pressure. (1.1) the treatment of chronic non-infectious uveitis affecting the posterior segment of the eye. (1.2)",
    "contraindications": "For ophthalmic intravitreal injection. (2.1) The intravitreal injection procedure should be carried out under aseptic conditions. (2.2) Following the intravitreal injection, patients should be monitored for elevation in intraocular pressure and for endophthalmitis. (2.2)",
    "warningsAndPrecautions": "ILUVIENÂ® (fluocinolone acetonide intravitreal implant) 0.19 mg is supplied in a sterile, single-use preloaded applicator with a 25-gauge needle, packaged in a tray sealed with a lid inside a carton.\n                  NDC 68611-190-02",
    "adverseReactions": "Ocular or Periocular Infections (4.1) Glaucoma (4.2) Hypersensitivity (4.3)"
}